Helicobacter pyloriprevalence shows a wide range, with rates of 80% in developing countries. The infection with H. pyloricauses high morbidity and mortality worldwide. Current treatment regimens ...

It has been forty years since the discovery of helicobacter pylori, a bacterial infection we now know is a common cause of ...

Bismuth quadruple therapy for 14 days is preferred regimen for treatment-naive patients when antibiotic susceptibility is unknown. William D. Chey, MD, from Michigan Medicine in Ann Arbor ...

The American Journal of Gastroenterology has published a new guideline on the treatment of Helicobacter pylori (H. pylori) ...

P-CAB dual regimen ranks highest for efficacy and safety in first-line treatment of H pylori infection, according to study findings.

Helicobacter pylori is a gram-negative bacterium that infects the stomach lining; it can cause gastrointestinal conditions such as gastritis or ulcers and can lead to an increased risk of stomach ...

“Once we understand the weakness of Helicobacter pylori (H.pylori), we can cure it. We are not frightened of H.pylori anymore,” Nobel laureate Barry J. Marshall, who discovered bacterium ...

Discover the effects of adding Helicobacter pylori stool antigen testing to colon cancer screening on rates of gastric cancer incidence and mortality.

Some estimates attribute as many as 20 percent of cancer cases to infectious agents, such as Epstein-Barr virus and hepatitis ...

pylori testing and treatment along with FIT would reduce ... Source Reference: Lee Y-C, et al "Screening for Helicobacter pylori to prevent gastric cancer: a pragmatic randomized clinical trial ...

TenNor Therapeutics has raised over 300 million yuan ($41 million) in a series E round, led by AMR Action Fund, to advance ...